Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I trial

American Heart Journal

Volumn 138, Issue 3 I, 1999, Pages 493-499

  Mahaffey, K W ^a   Granger, C B ^a   Sloan, M A ^a   Green, C L ^a   Gore, J M ^a   Weaver, W D ^a   White, H D ^a   Simoons, M L ^a   Barbash, G I ^a   Topol, E J ^a   Califf, R M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; DISABILITY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROSURGERY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032840435     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70152-3     Document Type: Article

References (22)

1. Third International Study of Infarct Survival (ISIS-3) Collaborative Group. A randomized comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70.
2. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
3. The GUSTO Investigators. An international randomized trial comparing thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
4. Sloan MA, Price TR, Petite CK, Randall AM, Solomon RE, Terrin ML, et al, for the TIMI Investigators. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction. Neurology 1995;45:649-58.
5. Gore JM, Granger CB, Simoons ML, Sloan MA, Weaver WD, White HD, et al. Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial. Circulation 1995;92:2811-8.
6. Simoons ML, Maggioni AP, Knatterud G, Leimberger JD, de Jaegere P, van Domburg R, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet 1993;342:1523-8.
7. Gore JM, Sloan M, Price TR, Randall AM, Bovill E, Collen D, et al, and the TIMI Investigators. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Circulation 1991;83:448-59.
8. de Jaegere PP, Arnold AA, Balk AH, Simoons ML. Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors. J Am Coll Cardiol 1992;19:289-94.
9. Maggioni AP, Franzosi MG, Santoro E, White H, Van De Werf F, Tognoni G, for the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2) International Study Group. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. N Engl J Med 1992;327:1-6.
10. Anderson JL, Karagounis L, Allen A, Bradford MJ, Menlove RL, Pryor TA. Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol 1991; 68:166-70.
11. Selker HP, Beshansky JR, Schmid CH, Griffith JL, Longstreth WT, O'Connor CM, et al. Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument (TPI) project results. Circulation 1994;90:1657-61.
12. Sloan MA, Sila CA, Mahaffey KW, Granger CB, Longstreth WT, Koudstaal P, et al for the GUSTO-I Investigators. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation 1998;98:1376-82.
13. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, et al for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.
14. Illingworth, RD. Burr holes, trephine, and craniotomy. In: Dudley H, Carter D, Russell RCG, editors. Operative surgery: neurosurgery. 4th ed. London: Butterworth; 1989. p. 12-29.
15. Anderson CS, Chakera TMH, Stewart-Wynne EG, Jamrozik KD. Spectrum of primary intracerebral hemorrhage in Perth, Western Australia, 1989-90: incidence and outcome. J Neurol Neurosurg Psychiatry 1994;57:936-40.
16. Bamford J, Sandercock P, Denis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry 1990;53:16-22.
17. Anderson CS, Jamrozik KD, Burvill PW, Chkera TMH, Johnson GA, Stewart-Wynne EG. Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke Study, 1989-90. Med J Aust 1993;158:85-9.
18. Hankey GJ, Hon C. Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials. Stroke 1997;28:2126-32.
19. McKissock W, Richardson A, Taylor J. Primary intracerebral haemorrhage: a controlled trial of surgical and conservative treatment in 180 unselected cases. Lancet 1961;1:221-6.
20. Auer LM, Deinsberger W, Niederkorn K, Gell G, Kleinert R, Schneider G, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 1989;70:530-5.
21. Juvela S, Heiskanen O, Poranen A, Valtonen S, Kuurne T, Kaste M, et al. The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative management. J Neurosurg 1989;70:755-8.
22. Batjer HH, Reisch JS, Allen BC, Plaizier LJ, Su CJ. Failure of surgery to improve outcome in hypertensive putamenal hemorrhage. A prospective randomized trial. Arch Neurol 1990;47:1103-6.